Average Co-Inventor Count = 7.79
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Opko Health, Inc. (15 from 26 patents)
2. Schering Corporation (5 from 1,829 patents)
3. Merck Sharp + Dohme Corp. (4 from 2,405 patents)
4. Recurium IP Holdings, LLC (2 from 27 patents)
5. Scherig Corporation (1 from 1 patent)
6. Slap Pharmaceuticals LLC (1 from 1 patent)
28 patents:
1. 12054479 - Multicyclic compounds
2. 11261192 - Substituted 1,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-ones
3. 11124518 - L,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-one analogs
4. 10196394 - Hydrochloride salts of 8-[1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diazaspiro[4,5]decan-2-one and preparation process therefor
5. 10000493 - Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
6. 9969711 - [object Object]
7. 9688693 - [object Object]
8. 9469629 - [object Object]
9. 9260428 - Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
10. 9169260 - Amidopyrazole inhibitors of interleukin receptor-associated kinases
11. 8796299 - NK1 antagonists
12. 8754216 - NK1 antagonists
13. 8716483 - Compounds that are ERK inhibitors
14. 8623857 - N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1
15. 8552191 - Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds